Page last updated: 2024-08-17

3,3'-diaminobenzidine and Lupus Erythematosus, Systemic

3,3'-diaminobenzidine has been researched along with Lupus Erythematosus, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buneva, VN; Nevinsky, GA; Tolmacheva, AS	1

Other Studies

1 other study(ies) available for 3,3'-diaminobenzidine and Lupus Erythematosus, Systemic

Article	Year
Substrate specificity of IgGs with peroxidase and oxidoreductase activities from sera of patients with systemic lupus erythematosus and multiple sclerosis. Journal of molecular recognition : JMR, 2019, Volume: 32, Issue:12 Topics: 3,3'-Diaminobenzidine; Adult; Female; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Middle Aged; Multiple Sclerosis; Oxidation-Reduction; Oxidoreductases; Peroxidases; Substrate Specificity; Young Adult	2019

Article

Year

Substrate specificity of IgGs with peroxidase and oxidoreductase activities from sera of patients with systemic lupus erythematosus and multiple sclerosis.

Journal of molecular recognition : JMR, 2019, Volume: 32, Issue:12

Topics: 3,3'-Diaminobenzidine; Adult; Female; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Middle Aged; Multiple Sclerosis; Oxidation-Reduction; Oxidoreductases; Peroxidases; Substrate Specificity; Young Adult

2019